Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.
Chadwick ML, Lane A, Thomas D, Smith AR, White AR, Davidson D, Feng Y, Boscolo E, Zheng Y, Adams DM, Gupta A, Veillette A, Chow LML.
Chadwick ML, et al. Among authors: smith ar.
Oncotarget. 2018 May 15;9(37):24750-24765. doi: 10.18632/oncotarget.25345. eCollection 2018 May 15.
Oncotarget. 2018.
PMID: 29872503
Free PMC article.